FOR IMMEDIATE RELEASE
Contact: Heather M. Tarczan
Chicago Area Patient Centered Outcomes Research Network (CAPriCORN) to Help Determine Best Aspirin Dose to Protect Patients with Heart Disease
First PCORnet Demonstration Study Could Help Guide Treatment Options for Millions
May 18, 2015 – Chicago Area Patient Centered Outcomes Research Network (CAPriCORN) will play a key role in a new $14 million research study announced today by the Patient-Centered Outcomes Research Institute (PCORI) to determine the best daily dose of aspirin to use in preventing heart attacks and strokes among people living with heart disease. CAPriCORN is one of six health system-based data networks that will conduct the three-year clinical trial funded by PCORI.
Please open attachment below to read more....